{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-016284","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2023-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.822808+00:00","generated_at":"2026-06-10T03:17:58.374364+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aytu BioPharma COO resigns; company winding down manufacturing, suspending R&D","bullets":["COO Christopher Brooke resigned effective Oct 13, 2023, to join a development-stage biotech.","Company will not replace COO due to wind down of manufacturing at Grand Prairie, TX facility.","All pipeline research and development programs are indefinitely suspended.","Resignation not due to any disagreement with company or auditors."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-016284","json":"https://secwatch.observer/filing/0001558370-23-016284.json","markdown":"https://secwatch.observer/filing/0001558370-23-016284.md","text":"https://secwatch.observer/filing/0001558370-23-016284.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000155837023016284/0001558370-23-016284-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000155837023016284/aytu-20231003x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:17:58.374364+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7f9667710c","claim":"Christopher Brooke resigned as Chief Operating Officer at AYTU BIOPHARMA, INC.","evidence_excerpt":"On October 3, 2023, Christopher Brooke resigned as Chief Operating Officer of Aytu BioPharma, Inc. (the “Company”), effective October 13, 2023, to pursue another opportunity at a development-stage biotechnology company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000155837023016284/0001558370-23-016284-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}